Merit Medical Systems | MMSI - Zinsaufwendungen Für Schuld

Aktienkurs
68.58
Täglich Wechseln
-0.03 -0.04%
Monatlich
0.69%
Jährlich
-27.51%
Q2 Prognose
67.11




Zinsaufwendungen Für Schuld Veränderung Datum
3M USD 214M 18M 2026-03
Abbott USD 68M 26M 2026-03
AngioDynamics USD 102K 2K 2025-09
Anika Therapeutics 189.44M 1.76M 2025-09
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 0 2026-03
Cooper Companies USD 22.4M 2M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Globus Medical USD 17K 5.1B 2025-12
Haemonetics USD 7.21M 3.14M 2025-09
ICU Medical USD 20.64M 21.39M 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
J&J USD 43M 25M 2026-03
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Olympus JPY 2.34B 2.94B 2025-12
Pfizer USD 711M 59M 2025-12
STAAR Surgical USD 800K 799K 2025-09
Stryker USD 157M 46.17B 2025-09
Surmodics USD 884K 5K 2024-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12